Bionano Genomics Inc (BNGO)
0.2824
0.00 (0.00%)
USD |
NASDAQ |
Nov 04, 16:00
0.2949
+0.01
(+4.43%)
After-Hours: 05:38
Bionano Genomics Enterprise Value: 24.70M for Nov. 4, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 24.70M |
| November 01, 2024 | 24.66M |
| October 31, 2024 | 25.34M |
| October 30, 2024 | 29.56M |
| October 29, 2024 | 27.34M |
| October 28, 2024 | 27.08M |
| October 25, 2024 | 26.72M |
| October 24, 2024 | 25.84M |
| October 23, 2024 | 25.77M |
| October 22, 2024 | 26.88M |
| October 21, 2024 | 27.98M |
| October 18, 2024 | 29.08M |
| October 17, 2024 | 28.45M |
| October 16, 2024 | 29.07M |
| October 15, 2024 | 28.78M |
| October 14, 2024 | 30.53M |
| October 11, 2024 | 32.25M |
| October 10, 2024 | 32.25M |
| October 09, 2024 | 36.58M |
| October 08, 2024 | 36.61M |
| October 07, 2024 | 37.68M |
| October 04, 2024 | 39.94M |
| October 03, 2024 | 38.17M |
| October 02, 2024 | 37.54M |
| October 01, 2024 | 36.95M |
| Date | Value |
|---|---|
| September 30, 2024 | 39.45M |
| September 27, 2024 | 40.25M |
| September 26, 2024 | 38.38M |
| September 25, 2024 | 35.15M |
| September 24, 2024 | 36.54M |
| September 23, 2024 | 34.82M |
| September 20, 2024 | 35.29M |
| September 19, 2024 | 36.54M |
| September 18, 2024 | 34.83M |
| September 17, 2024 | 36.55M |
| September 16, 2024 | 36.07M |
| September 13, 2024 | 37.41M |
| September 12, 2024 | 39.46M |
| September 11, 2024 | 41.69M |
| September 10, 2024 | 38.02M |
| September 09, 2024 | 38.69M |
| September 06, 2024 | 38.54M |
| September 05, 2024 | 39.63M |
| September 04, 2024 | 39.51M |
| September 03, 2024 | 40.39M |
| August 30, 2024 | 42.56M |
| August 29, 2024 | 41.97M |
| August 28, 2024 | 41.54M |
| August 27, 2024 | 44.50M |
| August 26, 2024 | 45.30M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-19.04M
Minimum
Oct 27 2023
4.210B
Maximum
Feb 16 2021
432.37M
Average
115.07M
Median
Apr 28 2023
Enterprise Value Benchmarks
| Revvity Inc | 17.31B |
| Bruker Corp | 11.01B |
| Azenta Inc | 1.602B |
| Harvard Bioscience Inc | 134.55M |
| Akoya Biosciences Inc | 160.15M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -16.22M |
| Revenue (Quarterly) | 7.771M |
| Total Expenses (Quarterly) | 23.57M |
| EPS Diluted (Quarterly) | -2.40 |
| Gross Profit Margin (Quarterly) | 33.26% |
| Profit Margin (Quarterly) | -208.8% |
| Earnings Yield | -2.54K% |
| Normalized Earnings Yield | -1843.46 |